epinephrine
epinephrine: 9 clinical trials tracked.
epinephrine evidence translation
What we can confirm
9 tracked trials
What it means
What to watch
Prepared research question
What is verified about epinephrine, and what remains unknown?
Traceable citations · Unknowns marked
See linked entities and source evidence7 indications · 2 study sponsors
Clinical Trial Registry Records (9)
A Phase 2, Open-label Clinical Study to Evaluate the Safety and Efficacy of MK-2010 as Monotherapy and in Combination
Primary endpoint: Number of Participants with Adverse Events (AEs)
Phase 2, Open-Label Study to Evaluate the Safety and Efficacy of MK-2010 in Combination With Sacituzumab Tirumotecan (Sac-TMT) in Participants With Advanced Solid Tumors
Primary endpoint: Number of Participants Who Experience an Adverse Event (AE)
Efficacy of Ropivacaine Epinephrine Clonidine Ketorolac (R.E.C.K) vs Exparel in Robotic Nephrectomy: a Randomized, Prospective Trial
Primary endpoint: Area Under the Curve (AUC) of the Numeric Rating Scale (NRS) pain intensity scores through 7 days (168 hours) for participants receiving Exparel vs. R.E.C.K.
An Outpatient, Randomized, Double-Blinded, Placebo-Controlled, Cross-Over Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria
Primary endpoint: Determine the effect of ARS-2 (0.5 mg or 1 mg) versus placebo on itch
A Randomized Controlled Trial of Bupivacaine With Epinephrine for Local Pain Control Following Perineal Laceration Repair in Patients With Pre-existing Epidural Analgesia: The PAIN Trial
Primary endpoint: Time to First Analgesic
A 2-Part, Phase 2, Open-Label, Randomized, Fixed Sequence Study to Evaluate the Pharmacokinetics and Pharmacodynamics of Epinephrine After Single and Repeat Doses of DESF in Healthy Adults With Oral Allergy Syndrome (OASIS: Oral Anaphylm Symptom Intervention Study)
Primary endpoint: Cmax
Multimodal Nonopioid Pain Protocol Following Shoulder Arthroplasty Surgery
Primary endpoint: Pain Levels
Intracoronary Administration of Epinephrine and Verapamil in the Refractory No-reflow Phenomenon in Patients With Acute Myocardial Infarction: The EPIVER Randomized Controlled Trial
Primary endpoint: Mortality
Phase I/II Trial of HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PD-L1/TGF-Beta Trap (M7824) in Subjects With HPV Positive Cancers
Primary endpoint: Safety and recommended phase II dose of PRGN-2009